211 related articles for article (PubMed ID: 27504339)
1. Systemic Sclerosis with Multiple Pulmonary Manifestations.
Kotnur MR; Suresh P; Reddy VS; Sharma T; Salim NA
J Clin Diagn Res; 2016 Jun; 10(6):OD16-7. PubMed ID: 27504339
[TBL] [Abstract][Full Text] [Related]
2. Variation of usual interstitial pneumonia using HRCT in Scleroderma Patients.
Wulani V; Budianto T; Amal MY
Radiol Case Rep; 2022 Feb; 17(2):336-339. PubMed ID: 34876961
[TBL] [Abstract][Full Text] [Related]
3. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
[TBL] [Abstract][Full Text] [Related]
4. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary involvement in systemic sclerosis.
Shahin AA
Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
7. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia.
Carbone RG; Monselise A; Barisione E; Fontana V; Paredi P; Puppo F
Intern Emerg Med; 2023 Jun; 18(4):1087-1093. PubMed ID: 37069417
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
10. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
11. Role of High-Resolution CT Thorax in Diagnosing Interstitial Lung Disease and Its Association With Smoking and Connective Tissue Disorder.
Doshi JA; Mundhra KS; Shah DS; Shah SN; Patel TV; Bhatt A
Cureus; 2022 Nov; 14(11):e31107. PubMed ID: 36475156
[TBL] [Abstract][Full Text] [Related]
12. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Fairley JL; Hansen D; Ross L; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Apostolopoulous D; Ferdowsi N; Wilson M; Tabesh M; Stevens W; Nikpour M;
Arthritis Res Ther; 2023 May; 25(1):77. PubMed ID: 37173780
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
15. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
[TBL] [Abstract][Full Text] [Related]
16. Systemic Sclerosis: Current State and Survival After Lung Transplantation.
Minalyan A; Gabrielyan L; Khanal S; Basyal B; Derk C
Cureus; 2021 Jan; 13(1):e12797. PubMed ID: 33628666
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis with interstitial lung disease and myocardial infarction: a case report.
Adhikari S; Poudel P; Pathak S
Ann Med Surg (Lond); 2023 Jun; 85(6):3043-3046. PubMed ID: 37363557
[TBL] [Abstract][Full Text] [Related]
18. Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.
Chatterjee S; Perelas A; Yadav R; Kirby DF; Singh A
Clin Rheumatol; 2023 Mar; 42(3):653-661. PubMed ID: 36271064
[TBL] [Abstract][Full Text] [Related]
19. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
